vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $124.7M, roughly 1.6× SMITH & WESSON BRANDS, INC.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 1.5%, a 6.7% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -3.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $16.3M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -4.8%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
COLL vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $124.7M |
| Net Profit | $17.0M | $1.9M |
| Gross Margin | 62.5% | 24.3% |
| Operating Margin | 29.6% | 3.3% |
| Net Margin | 8.3% | 1.5% |
| Revenue YoY | 12.9% | -3.9% |
| Net Profit YoY | 35.3% | -53.6% |
| EPS (diluted) | $0.48 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $124.7M | ||
| Q3 25 | $209.4M | $85.1M | ||
| Q2 25 | $188.0M | $140.8M | ||
| Q1 25 | $177.8M | $115.9M | ||
| Q4 24 | $181.9M | $129.7M | ||
| Q3 24 | $159.3M | $88.3M | ||
| Q2 24 | $145.3M | $159.1M | ||
| Q1 24 | $144.9M | $137.5M |
| Q4 25 | $17.0M | $1.9M | ||
| Q3 25 | $31.5M | $-3.4M | ||
| Q2 25 | $12.0M | $8.6M | ||
| Q1 25 | $2.4M | $2.1M | ||
| Q4 24 | $12.5M | $4.5M | ||
| Q3 24 | $9.3M | $-1.9M | ||
| Q2 24 | $19.6M | $27.9M | ||
| Q1 24 | $27.7M | $7.9M |
| Q4 25 | 62.5% | 24.3% | ||
| Q3 25 | 61.7% | 25.9% | ||
| Q2 25 | 57.7% | 28.8% | ||
| Q1 25 | 54.8% | 24.1% | ||
| Q4 24 | 54.0% | 26.6% | ||
| Q3 24 | 60.8% | 27.4% | ||
| Q2 24 | 62.5% | 35.5% | ||
| Q1 24 | 63.1% | 28.7% |
| Q4 25 | 29.6% | 3.3% | ||
| Q3 25 | 29.7% | -3.5% | ||
| Q2 25 | 18.7% | 9.3% | ||
| Q1 25 | 12.2% | 4.1% | ||
| Q4 24 | 20.9% | 5.8% | ||
| Q3 24 | 21.9% | -1.7% | ||
| Q2 24 | 32.7% | 17.4% | ||
| Q1 24 | 34.1% | 8.2% |
| Q4 25 | 8.3% | 1.5% | ||
| Q3 25 | 15.0% | -4.0% | ||
| Q2 25 | 6.4% | 6.1% | ||
| Q1 25 | 1.4% | 1.8% | ||
| Q4 24 | 6.9% | 3.5% | ||
| Q3 24 | 5.9% | -2.1% | ||
| Q2 24 | 13.5% | 17.5% | ||
| Q1 24 | 19.1% | 5.7% |
| Q4 25 | $0.48 | $0.04 | ||
| Q3 25 | $0.84 | $-0.08 | ||
| Q2 25 | $0.34 | $0.19 | ||
| Q1 25 | $0.07 | $0.05 | ||
| Q4 24 | $0.36 | $0.10 | ||
| Q3 24 | $0.27 | $-0.04 | ||
| Q2 24 | $0.52 | $0.60 | ||
| Q1 24 | $0.71 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $363.2M |
| Total Assets | $1.7B | $548.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $22.4M | ||
| Q3 25 | $285.9M | $18.0M | ||
| Q2 25 | $222.2M | $25.2M | ||
| Q1 25 | $197.8M | $26.7M | ||
| Q4 24 | $162.8M | $39.1M | ||
| Q3 24 | $120.0M | $35.5M | ||
| Q2 24 | $271.6M | $60.8M | ||
| Q1 24 | $318.0M | $47.4M |
| Q4 25 | $301.7M | $363.2M | ||
| Q3 25 | $274.8M | $364.4M | ||
| Q2 25 | $232.2M | $372.5M | ||
| Q1 25 | $234.4M | $366.9M | ||
| Q4 24 | $228.8M | $371.5M | ||
| Q3 24 | $234.3M | $380.0M | ||
| Q2 24 | $216.6M | $399.9M | ||
| Q1 24 | $222.2M | $376.4M |
| Q4 25 | $1.7B | $548.6M | ||
| Q3 25 | $1.6B | $554.6M | ||
| Q2 25 | $1.6B | $559.6M | ||
| Q1 25 | $1.6B | $578.9M | ||
| Q4 24 | $1.7B | $587.4M | ||
| Q3 24 | $1.6B | $571.3M | ||
| Q2 24 | $1.1B | $577.4M | ||
| Q1 24 | $1.1B | $570.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $27.3M |
| Free Cash FlowOCF − Capex | $122.4M | $16.3M |
| FCF MarginFCF / Revenue | 59.6% | 13.1% |
| Capex IntensityCapex / Revenue | 0.3% | 8.8% |
| Cash ConversionOCF / Net Profit | 7.25× | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $27.3M | ||
| Q3 25 | $78.4M | $-8.1M | ||
| Q2 25 | $72.4M | $40.8M | ||
| Q1 25 | $55.4M | $-9.8M | ||
| Q4 24 | $84.6M | $-7.4M | ||
| Q3 24 | $-9.0M | $-30.8M | ||
| Q2 24 | $67.4M | $43.7M | ||
| Q1 24 | $61.9M | $25.2M |
| Q4 25 | $122.4M | $16.3M | ||
| Q3 25 | $78.3M | $-12.4M | ||
| Q2 25 | $72.4M | $33.5M | ||
| Q1 25 | $54.6M | $-16.1M | ||
| Q4 24 | $84.1M | $-10.7M | ||
| Q3 24 | $-9.2M | $-35.5M | ||
| Q2 24 | $67.1M | $38.2M | ||
| Q1 24 | $61.4M | $7.0M |
| Q4 25 | 59.6% | 13.1% | ||
| Q3 25 | 37.4% | -14.6% | ||
| Q2 25 | 38.5% | 23.8% | ||
| Q1 25 | 30.7% | -13.9% | ||
| Q4 24 | 46.2% | -8.3% | ||
| Q3 24 | -5.8% | -40.2% | ||
| Q2 24 | 46.2% | 24.0% | ||
| Q1 24 | 42.3% | 5.1% |
| Q4 25 | 0.3% | 8.8% | ||
| Q3 25 | 0.1% | 5.0% | ||
| Q2 25 | 0.0% | 5.2% | ||
| Q1 25 | 0.4% | 5.4% | ||
| Q4 24 | 0.3% | 2.5% | ||
| Q3 24 | 0.2% | 5.3% | ||
| Q2 24 | 0.2% | 3.5% | ||
| Q1 24 | 0.4% | 13.2% |
| Q4 25 | 7.25× | 14.22× | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | 4.73× | ||
| Q1 25 | 22.92× | -4.68× | ||
| Q4 24 | 6.75× | -1.63× | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | 1.57× | ||
| Q1 24 | 2.23× | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
